Prevention of febrile neutropenia in chemotherapy – treated cancer patients : Pegylated versus standard myeloid colony stimulating factors. Do we have a choice ?

Auteurs : Klastersky J, Awada A
Jaar : 2011
Journal : Crit Rev Oncol Hematol
Volume : 78(1)
Pagina's : 17-23